drugset / Trial / NCT00116493

Severe Anemia Treatment Trials, Pakistan

NCT00116493

RandomizedFactorialTriple-blindTreatment

Summary

The purpose of this study is to test the efficacy of two enhanced regimens (deworming and multivitamins) in the treatment of severe anemia in pregnant women and children 6-24 months of age in Karachi, Pakistan.

Timeline

Start
2004-04
Primary completion
2007-05
Completion
2007-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Mebendazole Small molecule 100 mg
Subject Riboflavin Other / unclassified 0.5 mg
Subject Vitamin A Unknown 300 ug
Subject Vitamin B12 Other / unclassified 0.9 ug
Subject Vitamin C Other / unclassified 15 mg
Subject Vitamin E Other / unclassified 6 mg

Indications